V-Square Quantitative Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$692K Buy
2,914
+912
+46% +$190K 0.07% 258
2026
Q1
$423K Buy
2,002
+50
+3% +$10.8K 0.04% 341
2025
Q4
$401K Buy
+1,952
New +$367K 0.04% 350
2025
Q3
Sell
-2,860
Closed -$480K 216
2025
Q2
$480K Sell
2,860
-44
-2% -$6.53K 0.06% 303
2025
Q1
$400K Sell
2,904
-221
-7% -$28.2K 0.06% 350
2024
Q4
$370K Sell
3,125
-236
-7% -$27.6K 0.05% 370
2024
Q3
$371K Buy
3,361
+253
+8% +$26.5K 0.05% 372
2024
Q2
$306K Sell
3,108
-5,811
-65% -$592K 0.05% 362
2024
Q1
$998K Buy
8,919
+1,000
+13% +$108K 0.14% 119
2023
Q4
$798K Buy
7,919
+5,161
+187% +$512K 0.14% 116
2023
Q3
$239K Buy
2,758
+2,139
+346% +$193K 0.11% 256
2023
Q2
$58.5K Buy
+619
New +$52.3K 0.04% 285

Other funds holding CAH

V-Square Quantitative Management's CAH Position: Q2 2026 in Review

V-Square Quantitative Management increased its Cardinal Health (CAH) stake by 46% in Q2 2026, buying an estimated $190K and bringing the position to 2,914 shares worth $692K. The position accounts for 0.07% of the portfolio, ranked #258.

V-Square Quantitative Management first reported a position in CAH in Q2 2023 and has held it in 12 quarters since. The position peaked at $998K in Q1 2024. 568 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • V-Square Quantitative Management held 2,914 shares of Cardinal Health worth $692K as of Q2 2026.
  • V-Square Quantitative Management bought 912 Cardinal Health shares in Q2 2026, an estimated $190K.
  • Cardinal Health made up 0.07% of V-Square Quantitative Management's portfolio in Q2 2026, its #258 holding.
  • V-Square Quantitative Management first reported a position in Cardinal Health in Q2 2023 and has held it in 12 quarters since.
  • V-Square Quantitative Management's Cardinal Health position peaked at $998K in Q1 2024.
  • 568 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on V-Square Quantitative Management's 13F filing for Q2 2026, filed 27 Jul 2026.